Elevate Uranium Ownership
| ELVUF Stock | USD 0.16 0.01 5.88% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Elevate |
Elevate OTC Stock Ownership Analysis
About 17.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.01. Elevate Uranium had not issued any dividends in recent years. The entity had 1:100 split on the 5th of November 2014. Elevate Uranium Ltd engages in the exploration and evaluation of uranium deposits. Elevate Uranium Ltd was incorporated in 1978 and is headquartered in West Perth, Australia. Elevate Uranium operates under Uranium classification in the United States and is traded on OTC Exchange.The quote for Elevate Uranium is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. To learn more about Elevate Uranium call Fausimm BSc at 61 8 6555 1816 or check out https://www.elevateuranium.com.au.Currently Active Assets on Macroaxis
Other Information on Investing in Elevate OTC Stock
Elevate Uranium financial ratios help investors to determine whether Elevate OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Elevate with respect to the benefits of owning Elevate Uranium security.